Folgende wissenschftlichen Arbeiten wurden von GSASA-Mitgliedern in verschiedenen internationalen Zeitschriften publiziert. Klicken auf den jeweiligen Titel öffnet das entsprecende Abstract.
2013-5
Risk of incident stroke in patients with Alzheimer disease or vascular dementia
Patrick Imfeld, Michael Bodmer, Markus Schuerch, Susan S. Jick, and Christoph R. Meier |
Published in : Neurology. 2013;81(10):910-9 |
DOI: 10.1212/WNL.0b013e3182a35151 |
Role of P-glycoprotein in the uptake/efflux transport of oral vitamin K antagonists and rivaroxaban through the Caco-2 cell model
Liliane Gschwind, Victoria Rollason, Youssef Daali, Pascal Bonnabry, Pierre Dayer, Jules Desmeules |
Basic Clin Pharmacol Toxicol 2013;113:259-65 |
DOI: 10.1111/bcpt.12084 |
Administration des médicaments oraux chez le patient bénéficiant d’une nutrition entérale
Sébastien Neuville, Damien Lannoy, Catherine Delatre, Lucie Bouchoud |
Nutrition clinique et métabolisme. 2013; 27: 255–262 |
DOI:10.1016/j.nupar.2013.09.009 |
Nutrition parentérale et médicaments : modalités d’une administration concomitante
Lucie Bouchoud, Marie-Laure Duchêne, Odile Corriol, Sébastien Neuville |
Nutrition clinique et métabolisme. 2013; 27: 263–268 |
DOI: 10.1016/j.nupar.2013.08.001 |
Impact de recommandations locales sur la qualité du traitement médicamenteux après infarctus dans un hôpital régional
Vera von Gunten, Christophe Sierro, Séverine Pernoux, Marie-Laure Weibel, Pierre-Auguste Petignat, Grégoire Girod, Johnny Beney |
Rev Med Suisse 2013; 9 :2107-2111 |
Link |
Dosieraerosole: Wieviel Wirkstoff ist noch in der Patrone?
Phthalates in the NICU: Is it safe?
Céline Fischer-Fumeaux, Myriam Bickle Graz, Vincent Muehlethaler, David Palmero, Corinne Stadelmann, Jean-François Tolsa |
J Paediatr Child Health. 2013 Sep;49(9):E413-9. |
DOI:10.1111/jpc. 12244 |
Bupivacaine crystal deposits after long-term epidural infusion
I. Balga, H. Gerber, X.H. Schorno, F. Aebersold Keller, H.-P. Oehen |
Anaesthesist 2013; 65:543-548 |
DOI: 10.1007/s00101-013-2179-5 |
2013-4
Intravenous phenytoin: a retrospective analysis of Bayesian forecasting versus conventional dosing in patients
Andrea Tobler, Stefan Mühlebach |
Int J Clin Pharm. 2013 Jun 29 (online) |
DOI: 10.1007/s11096-013-9809-5 |
Impact of CYP2C9 polymorphisms on the vulnerability to pharmacokinetic drug-drug interactions during acenocoumarol treatment
Liliane Gschwind, Victoria Rollason, Françoise Boehlen, Michaela Rebsamen, Christophe Combescure, Michèle Grünenwald, Alain Matthey, Pascal Bonnabry, Pierre Dayer, Jules Desmeules |
Pharmacogenetics 2013;14:745-53 |
DOI: 10.2217/pgs.13.55 |
Risques d’erreurs liées au défaut d’identification des doses unitaires de médicaments
Validation of a once-a-week set up for an automated compounder device for parenteral nutrition solutions
Lucie Bouchoud, Farshid Sadeghipour, Sandrine Fleury-Souverain, Pascal Bonnabry |
Eur J Hosp Pharm 2013;20:236-40 |
doi:10.1136/ejhpharm-2012-000272 |
2013-3
Phthalates in the NICU: Is it safe?
Céline J. Fischer, Myriam Bickle Graz, Vincent Muehlethaler, David Palmero, Jean-François Tolsa |
Journal of Paediatrics and Child Health (2013) |
DOI:10.1111/jpc. 12244. |
Determination of the external contamination and cross-contamination by cytotoxic drugs on the surfaces of vials available on the Swiss market
Sandrine Fleury-Souverain, Susanne Nussbaumer, Marc Mattiuzzo, Pascal Bonnabry |
J Oncol Pharm Pract 2013; online. |
DOI: 10.1177/1078155213482683 |
Chemical contamination during the preparation of cytotoxics: validation protocol for operators in hospital pharmacies
Farshid Sadeghipour, Kuntheavy Ing Lorenzini, Catrin Ziewitz, Maria Dobrinas, Mapi Fleury, Pascal Bonnabry |
Antimicrob Agents Chemother. 2013; 57: 1709-13 |
DOI: 0.1177/1078155212452764 |
Patented drug extension strategies on healthcare spending: a cost-evaluation analysis
Nathalie Vernaz, Guy Haller, François Girardin, Benedikt Huttner, Christophe Combescure, Pierre Dayer, Daniel Muscionico, Jean-Luc Salomon, Pascal Bonnabry |
PLoS Medicine 2013; 10(6): e1001460. |
doi:10.1371/journal.pmed.1001460 |
2013-2
Letters to the Editor : Evolving Trends in the Costs Associated With Hospital Use of Immunosuppressive Drugs
Nancy Perrottet, Vincent Aubert, Jean-Pierre Venetz. Enrico Ugolini, Maurice Matter, André Pannatier, Manuel Pascual |
Transplantation (2013) |
DOI:10.1097/TP.0b013e318281393c |
Development of a standardised method to recommend protective measures to handle hazardous drugs in hospitals
Laure-Zoé Kaestli, Caroline Fonzo-Christe, Chantal Bonfillon, Jules Desmeules, Pascal Bonnabry |
Eur J Hosp Pharm 2013;20:100–105 |
DOI: 10.1136/ejhpharm-2012-000222 |
Impact of antibiotic use on carbapenem resistance in Pseudomonas aeruginosa: Is there a role for antibiotic diversity?
Catherine Plüss-Suard, André Pannatier, Andreas Kronenberg, Kathrin Mühlemann, Giorgio Zanetti |
Antimicrob Agents Chemother. 2013; 57: 1709-13 |
DOI: 10.1128/AAC.01348-12 |
Identification and weighting of the most critical "real-life" drug-drug interactions with acenocoumarol in a tertiary care hospital
Liliane Gschwind, Victoria Rollason, Christian Lovis, Françoise Boehlen, Pascal Bonnabry, Pierre Dayer, Jules Desmeules |
Eur J Clin Pharmacol 2013;69:617-27 |
DOI: 10.1007/s00228-012-1358-7 |
Epidemiology, Co-morbidities and Medication Use of Patients with Alzheimer’s Disease or Vascular Dementia in the UK
Patrick Imfeld, Yolanda B. Brauchli Pernu, Susan S. Jick, Christoph R. Meier |
J Alzheimers Dis. (2013) |
DOI: 10.3233/JAD-121819 |
Systematic review of population pharmacokinetic analyses of imatinib and relationships with treatment outcomes
Verena Gotta, Thierry Bucli1, Chantal Csajka, Nicolas Widmer |
Ther Drug Monit (2013) |
DOI: 10.1097/FTD.0b013e318284ef11 |
Détermination d’un indicateur d’activité pertinent pour les préparations en pharmacie hospitalière : comparaison interétablissements de la préparation des chimiothérapies
C. Malbranche, S. Lamon, I. Roland, D. Jacob, M. Duban, C. Pernot |
Le pharmacien hospitalier et clinicien (2013)Le pharmacien hospitalier et clinicien (2013) |
DOI: 10.1016/j.phclin.2012.05.005 |
2013-1
In vitro compatibility of various cardioactive drugs during simulated Y-site administration
Valia Humbert-Delaloye, Markoulina Berger-Gryllaki, Pierre Voirol, Laurent Gattlen, André Pannatier |
Eur J Hosp Pharm (2013) |
DOI:10.1136/ejhpharm-2012-000239 |
Compatibility of Intravenous Medications With Parenteral Nutrition: In Vitro Evaluation.
Lucie Bouchoud, Caroline Fonzo-Christe, Martin Klingmüller, Pascal Bonnabry |
JPEN J Parenter Enteral Nutr. (2012) |
OI: 10.1177/0148607112464239 |
Randomized Trial of a Clinical Dosing Algorithm to Start Anticoagulation with Phenprocoumon
Angela Caduff Good, Daniel Nobel, Stephan Krähenbühl, Christof Geisen, Samuel Henz |
Swiss Med Wkly (2013) |
DOI:10.4414/smw.2013.13709 |
Seizures in patients with Alzheimer’s disease or vascular dementia: A population-based nested case–control analysis
Patrick Imfeld, Michael Bodmer, Markus Schuerch, Susan S. Jick, and Christoph R. Meier |
Epilepsia (2012) |
DOI: 10.1111/epi.12045 |
Pediatric drug-related problems: a multicenter study in four French-speaking countries
Sonia Prot-Labarthe, Ermindo R. Di Paolo, Annie Lavoie, Stefanie Quenner, Jean-François Bussières, Françoise Brion, Olivier Bourdon |
Int J Clin Phar (2012) |
DOI:10.1007/s11096-012-9740-1 |
Albuterol Delivery in an In Vitro Pediatric Ventilator Lung Model: Comparison of Jet, Ultrasonic and Mesh Nebulizers
Anne-Laure Sidler-Moix, Ugo Dolci, Markoulina Berger-Gryllaki, André Pannatier, Jacques Cotting, Ermindo R. Di Paolo |
Pediatric Critical Care Medicine (2013) |
DOI:10.1097/PCC.0b013e3182712783 |
In Vitro Evaluation of Decontamination Efficacy of Cleaning Solutions on Stainless Steel and Glass Surfaces Contaminated by 10 Antineoplastic Agents.
Thomas Queruau Lamerie, Susanne Nussbaumer, Bertrand Décaudin, Sandrine Fleury-Souverain, Jean-François Goossens, Pascal Bonnabry, Pascal Odou |
Ann Occup Hyg. (2012) |
DOI: 10.1093/annhyg/mes087 |
Accuracy of preparation of i.v. medication syringes for anesthesiology.
Cyril Stucki, Anna-Maria Sautter, Adriana Wolff, Sandrine Fleury-Souverain, Pascal Bonnabry |
Am J Health Syst Pharm. (2013) |
DOI: 10.2146/ajhp110654 |